AISA, acronym of Anti Inflammatory Senescence Actives, is a start-up created by Pr d’Alessio following her national award for Innovation. Focused on the research and development of new anti-inflammatory / anti-senescence molecules as an alternative to steroidal and non-steroidal anti-inflammatory drugs and anti-TNF drugs, AISA Therapeutics displays a consequent patent portfolio covering about 50 claims in human and animal health granted in Europe, USA and China.